Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/1991
11/28/1991WO1991018021A1 New lysozyme-digestive chitin derivative
11/28/1991WO1991018007A1 Phthalocyanatopolyethylene glycol, and phthalocyanato saccharides as fluorescent digoxin reagents
11/28/1991WO1991018006A1 Fluorescent porphyrin, and fluorescent phthalocyanine - polyethylene glycol, polyol, and saccharide derivatives as fluorescent probes
11/28/1991WO1991017774A1 Inclusion compounds of nimesulide with cyclodextrins
11/28/1991WO1991017773A2 New protein-polycation conjugates
11/28/1991WO1991017772A1 Controlled release dopamine and its use to stimulate nerve fiber growth
11/28/1991WO1991017770A1 Synergistic tumor therapy with combinations of biologically active anti-tumor antibodies and chemotherapy
11/28/1991WO1991017765A1 Fibrin binding domain polypeptides and uses and methods of producing same
11/28/1991DE4116659A1 Nimesulid inclusion cpds. with cyclodextrin - more water-soluble with improved bio-availability than nimesulid alone
11/28/1991CA2083391A1 Synergistic tumor therapy with combinations of biologically active anti-tumor antibodies and chemotherapy
11/27/1991EP0458751A1 Delivery system for cyclic amino acids with improved taste, texture and compressibility
11/27/1991EP0458745A1 Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography
11/27/1991EP0458588A1 Treatment of ocular hypertension with a synergistic combination for ocular administration
11/27/1991EP0458064A2 Stabilization of somatotropins and other proteins by modification of cysteine residues
11/27/1991EP0457916A1 Plasma-irradiated solid preparation
11/27/1991EP0457875A1 Chimeric mouse-human a10 antibody with specificity to a human tumor cell antigen
11/27/1991EP0457849A1 Electrotransport adhesive.
11/26/1991US5068272 Salt with 4-(3-(ethyl-(3-(propylsulfinyl)propyl)amino)-2-hydroxypropoxy)benzonitrile
11/26/1991US5068249 Histamine H2 antagonist, (N-(2-(((5-(dimethylamino)methyl-2-furanyl)-methyl)thio)ethyl)-N'-methyl-2 -nitro-1,1-ethenediamine
11/26/1991US5068227 Antibodies and active materials coupled to cyclodextrins
11/26/1991US5068226 Pharmaceutical preparations containing cyclodextrins and their use in iontophoretic therapies
11/26/1991US5068109 Antacid composition
11/26/1991US5068106 Tissue plasminogen activator in protein solution
11/26/1991US5068064 N-substituted lauramides, their preparation and compositions in which they are present
11/26/1991CA2043153A1 Delivery system for cyclic amino acids with improved taste, texture and compressibility
11/21/1991EP0457333A2 Topical composition
11/21/1991EP0457250A2 Novel bifunctional linking compounds, conjugates and methods for their production
11/21/1991EP0457223A1 Stabilized fibroblast growth factor composition
11/21/1991EP0457127A2 Spermicidal coating
11/21/1991EP0325628B1 Agent containing salicylic acid for treating lepidosis
11/19/1991US5066789 Targeting substance-diagnostic/therapeutic agent conjugates having Schiff base linkages
11/19/1991US5066648 Pyroglutamic acid esters used as dermal penetration enhancers for drugs
11/19/1991US5066647 Freeze dried, quick dissolving, improved shelf life
11/19/1991US5066590 Superoxide dismutase combined with a poly(alkylene oxide)
11/19/1991US5066490 Protein crosslinking reagents cleavable within acidified intracellular vesicles
11/19/1991US5066488 Semi-anhydrous, suspension process for preparing uniform, free-flowing, fine, white powders of substantially anhydrous complexes of PVP and H2 O2 containing about 18 to about 22% H2 O2
11/18/1991WO1991018020A1 Complex for in-vivo target localization
11/18/1991CA2082943A1 Complex for in-vivo target localization
11/18/1991CA2038899A1 Method for controlled dermal penetration and topical compositions useful therefor
11/17/1991CA2042458A1 Oligophosphates with an antiviral action
11/17/1991CA2017037A1 Composition for treatment of progressive myopia
11/16/1991CA2042569A1 Stabilized fgf composition
11/16/1991CA2042333A1 Spermicidal coating composition
11/15/1991WO1991018012A1 Cell internalizable conjugates and complexes including intracellularly cleavable moieties
11/15/1991CA2059649A1 Cell internalizable conjugates and complexes including intracellularly cleavable moieties
11/14/1991WO1991016930A1 Composition for transdermal penetration of medicaments
11/14/1991WO1991016929A1 A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols
11/14/1991WO1991016916A1 Antineoplastic agent
11/14/1991WO1991016899A1 Composition for solid pharmaceutical preparations containing vitamin d3 derivative and process for preparation thereof
11/14/1991WO1991016881A1 Colonic drug delivery system
11/14/1991WO1991015244A3 Stable microbubbles suspensions injectable into living organisms
11/14/1991DE4014540A1 Immune conjugates for prophylaxis and treatment of organ damage - caused by inflammation, esp. sepsis, contain monoclonal antibody, crosslinker and enzyme inhibitor of protein kinase C or calcium antagonist
11/14/1991CA2082156A1 Colonic drug delivery system
11/14/1991CA2081569A1 Composition for solid pharmaceutical preparations containing vitamin d3 derivative and process for preparation thereof
11/13/1991EP0456229A2 Arylsulfatase
11/13/1991EP0456153A1 Galenical aqueous formulations containing erythropoietin and use thereof
11/13/1991EP0455735A1 Avidin-biotin assisted immunoassay.
11/13/1991EP0455631A1 Preparation containing salicylic acid for treating desquamative skin diseases.
11/13/1991CN1056058A Contrast media
11/13/1991CN1056056A Composition and method for controlling cholesterol
11/13/1991CN1056055A Percutaneously absorbable eperisone or tolperisone preparation
11/12/1991WO1991017761A1 Targeted protection from cytotoxins
11/12/1991US5064956 Process for preparing mono-n-alkylated polyazamacrocycles
11/12/1991US5064857 Liquid bismuth containing medicinal product, process for producing it and its use
11/12/1991US5064829 Composition of a b vitamin and mannitol and a method for production
11/12/1991US5064817 Phospholipase a2 inhibiting compositions and their use
11/12/1991US5064815 Primycin-containing colloidal basic gel
11/12/1991US5064655 Liposome gel composition and method
11/12/1991CA2082507A1 Targeted protection from cytotoxins
11/11/1991CA2041280A1 Arylsulfatase
11/10/1991WO1991017300A1 Non-destructive carriers for cyclodextrin complexes
11/10/1991WO1991016883A1 Controlled release vehicle
11/10/1991CA2082496A1 Controlled release vehicle
11/09/1991WO1991016824A1 Cholesterol removal
11/09/1991CA2082388A1 Cholesterol removal
11/08/1991WO1991017173A1 Molecular recognition units
11/08/1991CA2082272A1 Molecular recognition units
11/06/1991EP0455599A1 Flavor enhancing and medicinal taste masking agent
11/06/1991EP0455528A1 Cosmetic or dermopharmaceutical composition containing vesicles formed of a mixture of phospholipies/glycolipids
11/06/1991EP0455503A1 Composition for treating osteoporosis and hormonal imbalance
11/06/1991EP0455396A1 Aqueous gel compositions and their use
11/06/1991EP0455391A2 Granulated preparations and method of producing the same
11/06/1991EP0455268A1 Biologically useful conjugates
11/06/1991EP0454898A1 Glycosaminoglycan-modified protein, process for the production of this protein, use and pharmaceutical compositions containing the same
11/06/1991EP0454773A1 Novel prodrug derivatives of biologically active agents containing hydroxyl groups or nh-acidic groups
11/06/1991EP0454726A1 Hindered linking agents and methods
11/06/1991CN1055928A Complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for preparation thereof, and pharmaceutical compositions containing same
11/06/1991CN1055879A Antibody conjugates for treatment of neoplastic disease
11/06/1991CN1055874A Aqueous ophthalmic solutions and method for preserving same
11/05/1991WO1991017170A1 Multimeric gelsolin fusion constructs
11/05/1991US5063220 Parenteral formulations of 1-diphenylmethyl-4-((2-(4-methylphenyl)-5-methyl-1H-imidazol-4-yl)methyl)piperazine
11/05/1991US5063064 Lithium fluoride
11/05/1991US5063061 Antiallergens
11/05/1991CA2063593A1 Multimeric gelsolin fusion constructs
11/05/1991CA2041799A1 Composition for treating osteoporosis and hormonal imbalance
11/05/1991CA2041742A1 Stabilization of somatotropins and other proteins by modification of cysteine residues
11/05/1991CA1291708C Solubilization of proteins for pharmaceutical compositions using polymer conjugation
11/04/1991CA2041703A1 Flavor enhancing and increasing efficacy of cough drops
11/04/1991CA2041702A1 Flavor enhancing and medicinal taste masking agent
11/03/1991CA2040996A1 Composition and method for controlling cholesterol
1 ... 1622 1623 1624 1625 1626 1627 1628 1629 1630 1631 1632 1633 1634 1635 1636 1637 1638 1639 1640 1641 1642 ... 1712